Location: Home
  • search
  • go
  • Relate News
  • 3/3/2023JPO Issues Bidding Documents for the 8th Round of Volume-Based Procure...
  • 3/3/2023China: Commercial Health Insurance Trends (Simon Kucher)
  • 3/2/2023China's NRDL Adds 121 New Products, Prices Slashed by An Average Of 60...
  • 3/1/2023NHSA Issues the Notice on Centralized Drug Procurement and Price Contr...
  • 2/28/2023Northeast Pharma Fined $19M for Jacking Up Drug Ingredient Prices
  • 2/28/2023Four Central Government Agencies Issue the Measures for Ethical Review...
  • 2/28/2023Financial-related Company News Digest (February 2023)
  • 2/28/2023Why China's Rare Disease Burden Could Be An Opportunity for Innovation...
  • 2/28/2023Lesson from China's National Negotiation of Drug Prices in 2022 (NLR)
  • 2/27/2023Eucure and Chipscreen NewWay Enter into Greater China License Agreeme...
  • 2/27/2023HKUST, PhIRDA Launch Innovation and Research Platforms
  • 2/24/2023China Introduces New Policy to Deepen Reform and Promote Development o...
  • 2/24/2023SMEI: Chinese Pharma Revenues Down 1.6% Last Year But Expected to Rebo...
  • 2/24/2023IQVIA: Chinese Hospital Drug Market Shrank 2.1% in 2022
  • 2/24/2023Recent Official and Executive Moves
  • 2/24/2023Drug R&D and Product Registration News Digest February 2023 (4)
  • 2/24/2023The Out-Licensing Boom Continues, Orphan Drugs May Be on the Rise (Pha...
  • 2/24/2023AI, ChatGPT And The Future Of Drug Discovery: China Biotech CEO Podcas...
  • 2/23/2023China Proposes to Prohibit Export of Certain Human Cell Cloning and Ge...
  • 2/23/2023Kinnate Buys Back $24M Worth of Stake in Its Chinese JV Kinnjiu
  • 2/23/2023AstraZeneca Licenses Potential Gastric Cancer Drug from KYM Bioscience...
  • 2/23/2023Chinese Mental Health Improved Last Year Although Prevalence in Youths...
  • 2/22/2023GlobalData: Chinese Regulators Focus on Homegrown COVID-19 Therapies t...
  • 2/21/2023Chinese Pharma Cos Pulled Off Eight Outlicensing Deals in Early 2023
  • 2/21/2023CDE Issues the Technical Guidelines for Clinical Research of Type 2 Di...
  • 2/21/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (67...
  • 2/21/2023PharmaDJ's China NMPA Drug Approval Tracker January 2023 (PharmaDJ)
  • 2/20/2023CDE Issued 60 New Technical Guidelines in 2022, Emphasizing Clinical R...
  • 2/20/2023Clover, Adimmune Tie Up to Commercialize Quadrivalent Seasonal Flu Vac...
  • 2/20/2023CDE Issues the Technical Guidelines for Pharmaceutical Research of Che...
  • Page:111/775 Total number of articles:23243: [First][<<] [109] [110] [111] [112] [113] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group